Web Exclusives
Web Exclusives — April 20, 2020
In April 2020, the FDA approved Jelmyto as the first treatment for low-grade upper-tract urothelial cancer, a rare cancer that affects the urinary system. Read More ›
Web Exclusives — April 20, 2020
People with chronic lymphocytic leukemia (CLL) can experience improvements in the way their care is managed by using a free telehealth program that connects patients with doctors who specialize in the disease. Read More ›
Web Exclusives — March 20, 2020
LUNGevity and 4 other lung cancer organizations have provided information on the new coronavirus for people with lung cancer and other patients with cancer. This update also provides reliable sources of information for patients. Read More ›
Web Exclusives — March 19, 2020
LUNGevity answers some frequently asked questions about patients with lung cancer and survivors and the coronavirus illness. Read More ›
Web Exclusives — March 18, 2020
COVID-19, the respiratory infection caused by the new coronavirus, is making headlines around the world. Find out what you need to know about this global disease outbreak and how to protect yourself. Read More ›
Web Exclusives — March 17, 2020
Today, more people, including patients diagnosed with chronic lymphocytic leukemia, are living longer with cancer thanks to advancements in cancer treatments. Improvements in the chance for long-term cancer remission are clearly important but living with cancer can also bring a new set of challenges. Read More ›
Web Exclusives — March 17, 2020
People with cancer, including people who have been diagnosed with chronic lymphocytic leukemia, do not need to face it alone. Valuable online and local resources are available for patients with cancer and their loved ones. Read More ›
Web Exclusives — March 17, 2020
For many patients with chronic lymphocytic leukemia (CLL), treatment is personalized. This means that oncologists tailor their medication choices based on the patient’s unique CLL characteristics and medical status. Read More ›
Web Exclusives — March 17, 2020
Targeted therapies are effective in controlling chronic lymphocytic leukemia (CLL). New research is now looking into the impact that these agents can have on autoimmune conditions. Read More ›
Web Exclusives — March 17, 2020
A new type of immunotherapy, allogeneic cord blood–derived CAR NK-cells, could be a future option for patients with chronic lymphocytic leukemia (CLL), based on results from an early-phase clinical trial showing high response rates among patients. Read More ›